ClinVar Miner

Submissions for variant NM_006019.4(TCIRG1):c.90C>T (p.Gly30=)

gnomAD frequency: 0.00162  dbSNP: rs141859450
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000393916 SCV000336503 uncertain significance not provided 2015-10-22 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000765009 SCV000373693 uncertain significance Autosomal recessive osteopetrosis 1 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Fulgent Genetics, Fulgent Genetics RCV000765009 SCV000896192 uncertain significance Autosomal recessive osteopetrosis 1 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV000393916 SCV001099504 likely benign not provided 2024-01-30 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000393916 SCV002544581 uncertain significance not provided 2023-09-01 criteria provided, single submitter clinical testing TCIRG1: PM2:Supporting, PP3
GeneDx RCV000393916 SCV004170251 uncertain significance not provided 2023-03-27 criteria provided, single submitter clinical testing In silico analysis supports a deleterious effect on splicing; Has not been previously published as pathogenic or benign to our knowledge
Natera, Inc. RCV000765009 SCV001458801 uncertain significance Autosomal recessive osteopetrosis 1 2020-04-15 no assertion criteria provided clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000393916 SCV001549154 uncertain significance not provided no assertion criteria provided clinical testing The TCIRG1 p.Gly30Gly variant was not identified in the literature but was identified in dbSNP (ID: rs141859450) and ClinVar (classified as uncertain significance by EGL Genetics, Fulgent Genetics and Illumina). The variant was identified in control databases in 398 of 280570 chromosomes at a frequency of 0.001419 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 328 of 127460 chromosomes (freq: 0.002573), Other in 17 of 7166 chromosomes (freq: 0.002372), European (Finnish) in 31 of 24938 chromosomes (freq: 0.001243), Latino in 17 of 35400 chromosomes (freq: 0.00048), African in 3 of 24796 chromosomes (freq: 0.000121), Ashkenazi Jewish in 1 of 10290 chromosomes (freq: 0.000097) and South Asian in 1 of 30596 chromosomes (freq: 0.000033), but was not observed in the East Asian population. The p.Gly30Gly variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. However, 4 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. However, this has not been confirmed by RNA analysis and is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.